enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Artificial tears - Wikipedia

   en.wikipedia.org/wiki/Artificial_tears

   A 2016 Cochrane Review seeking to compare the effectiveness of various over the counter artificial tears in treating dry eye. While the review stated that it is unclear which artificial tear formulation works best, two trials found that 0.2% polyacrylic acid-based tears were more effective in treating dry eye symptoms over 1.4% polyvinyl ...

3. Over 27 Eye Drops Have Been Recalled: What You Need to Know - AOL

   www.aol.com/eye-drop-recall-know-113000380.html

   Find a list of recalled drops in 2023. Plus, eye infection symptoms. Eye drops are being recalled due to a rare bacterium found in artificial tears. Find a list of recalled drops in 2023.

4. A Full List of Recalled Eye Drops Linked to Potential ... - AOL

   www.aol.com/full-list-recalled-eye-drops...

   Brimonidine Tartrate Ophthalmic Solution, 0.15%: A special tool designated for those with glaucoma or ocular hypertension, a small subset of these eye drops are being voluntarily recalled as ...

5. Eye drop - Wikipedia

   en.wikipedia.org/wiki/Eye_drop

   Eye drops being applied These eye drops are packaged for single use, without preservatives. Eye drops or eyedrops are liquid drops applied directly to the surface of the eye usually in small amounts such as a single drop or a few drops. Eye drops usually contain saline to match the salinity of the eye.

6. More eye medicine recalled in 13-state outbreak of ‘drug ...

   www.aol.com/news/more-eye-medicine-recalled-13...

   For premium support please call: 800-290-4726 more ways to reach us

7. Perfluorohexyloctane - Wikipedia

   en.wikipedia.org/wiki/Perfluorohexyloctane

   Perfluorohexyloctane has been available in multiple markets since 2015 under the brand names Evotears and Novatears, [3] and was additionally approved for medical use in the United States in May 2023 under the brand name Miebo. [2] [4] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [5]